STRONGBRIDGE BIOPHARMA PLC ORDINARY SHARES (SBBP) Covered Calls

You can sell covered calls on STRONGBRIDGE BIOPHARMA PLC ORDINARY SHARES to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for SBBP (prices last updated Wed 4:16 PM ET):

STRONGBRIDGE BIOPHARMA PLC ORDINARY SHARES (SBBP) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
5.05 -1.20 4.75 4.95 1.9M - 0.3B
Covered Calls For STRONGBRIDGE BIOPHARMA PLC ORDINARY SHARES (SBBP)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Aug 17 5 0.25 4.70 5.3% 645%
Sep 21 5 0.75 4.20 17.9% 172%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Strongbridge Biopharma plc, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs. The company's commercial products include Keveyis, an oral carbonic anhydrase inhibitor for treating hyperkalemic, hypokalemic, and related variants of primary periodic paralysis in the United States; and Macrilen, an oral growth hormone secretagogue receptor agonist for use in the diagnosis of patients with adult growth hormone deficiency in the United States and Canada. Its clinical-stage product candidates are Recorlev, a cortisol synthesis inhibitor, which is in a Phase III clinical trial that is used for the treatment of endogenous Cushing's syndrome; and Veldoreotide, a somatostatin analog that is used for treatment of acromegaly. The company was formerly known as Cortendo plc and changed its name to Strongbridge Biopharma plc in September 2015. Strongbridge Biopharma plc was founded in 1996 and is headquartered in Trevose, Pennsylvania